We are minority, women-owned small business in the drug discovery and research field since 2006. We collaborate and/or provide computational chemistry & molecular modeling support for developing highly predictive QSAR / QSTR models for efficacy / toxicity predictions based on technologies, such as chemical functions (pharmacophore / toxicophore), molecular fields (CoMFA, CoMSIA), physicochemical properties (2D, 3D) in conjunction with our niche ‘BioActive Conformation Mining Methodology’ (BACM). We have experience working with federal agency (DoD) research laboratories (WRAIR, USAMRICD). We would highly appreciate working for FDA developing predictive and mechanistically insightful QSTR models for toxicity predictions and insights into mechanism of toxicity.
Astha Consultancy, Inc - Comment
This is comment on Notice
Draft Reports; Availability: Identifying Center for Drug Evaluation and Research's Science and Research Needs
View Comment
Attachments:
Astha Consultancy, Inc - Comment, Astha_Brochure
Title:
Astha Consultancy, Inc - Comment, Astha_Brochure
Related Comments
View AllPublic Submission Posted: 09/22/2011 ID: FDA-2011-D-0239-0003
Sep 26,2011 11:59 PM ET
Public Submission Posted: 09/22/2011 ID: FDA-2011-D-0239-0007
Sep 26,2011 11:59 PM ET
Public Submission Posted: 09/22/2011 ID: FDA-2011-D-0239-0009
Sep 26,2011 11:59 PM ET
Public Submission Posted: 10/11/2011 ID: FDA-2011-D-0239-0010
Sep 26,2011 11:59 PM ET
Public Submission Posted: 10/11/2011 ID: FDA-2011-D-0239-0012
Sep 26,2011 11:59 PM ET